Correlation between immunohistochemistry and FISH for HER-2 in 441 breast carcinomas from multiple hospitals

被引：0
作者：
Dowsett, M
Ellis, IO
Bartlett, JMS
Salter, J
Lowe, F
Wencyk, PM
Pinder, SE
Paish, C
Bell, JA
Walters, AD
Cooke, TG
机构：
[1] Royal Marsden Hosp, London SW3 6JJ, England
[2] City Hosp, Nottingham NG5 1PB, England
[3] Royal Infirm, Glasgow G31 2ER, Lanark, Scotland
来源：
JOURNAL OF PATHOLOGY | 2001年 / 195卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5A / 5A
页数：1
相关论文
共 50 条
  • [31] Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assessment for Her-2 status in breast cancer
    Sui, Weiguo
    Ou, Minglin
    Chen, Jiejing
    Wan, Youhua
    Peng, Hongbo
    Qi, Minfang
    Huang, He
    Dai, Yong
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2009, 7 : 83
  • [32] Evaluation of oestrogen and progesterone receptor status in HER-2 positive breast carcinomas and correlation with outcome
    Francis, Glenn
    Beadle, Geoffrey
    Thomas, S.
    Mengersen, K.
    Stein, Sandra
    PATHOLOGY, 2006, 38 (05) : 391 - 398
  • [33] Correlation of Her-2/neu results by immunohistochemistry and fluorescence in situ hybridization with survival in breast cancer.
    Kakar, S
    Puangsuvan, N
    Mihalov, ML
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (04) : 656 - 656
  • [34] Immunoexpression of Her-2, neuregulin, MAPK, Akt in breast carcinomas
    Kaya, Handan
    Erbarut, Ipek
    Ozkan, Nazjye
    Bekiroglu, Nural
    VIRCHOWS ARCHIV, 2007, 451 (02) : 204 - 205
  • [35] Analysis of discordance in HER-2 over-expressed (3+)/FISH negative breast carcinomas
    Bloom, K. J.
    MODERN PATHOLOGY, 2007, 20 : 25A - 25A
  • [36] Extremely high concordance between immunohistochemistry and FISH testing for HER-2/neu status in breast cancer: a study of 6720 cases.
    Gown, A. M.
    Goldstein, L. C.
    Barry, T. S.
    Kussick, S. L.
    Kandalaft, P. L.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S218 - S218
  • [37] Correlation of serum HER-2/neu extracellular domain levels in metastatic breast cancer with the expression of HER-2/neu determined by immunohistochemistry in primary tumors.
    Witzel, I
    Thomssen, C
    Pantel, K
    Neumann, R
    Carney, W
    Loening, T
    Jaenicke, F
    Mueller, V
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S143 - S143
  • [38] The correlation between HER-2 expression and the CEUS and ARFI characteristics of breast cancer
    Wang, Xiao-Yan
    Hu, Qiao
    Fang, Meng-Yuan
    He, Yan
    Wei, Hai-Ming
    Chen, Xue-Xue
    Zhang, Bing
    PLOS ONE, 2017, 12 (06):
  • [39] Analysis of discordance in HER-2 over-expressed (3+)/FISH negative breast carcinomas
    Bloom, K. J.
    LABORATORY INVESTIGATION, 2007, 87 : 25A - 25A
  • [40] Significance of intratumoural HER-2 heterogeneity in invasive breast carcinomas
    Ravazoula, P.
    Koumoundourou, D.
    Nikolatou, E.
    Michael, G.
    VIRCHOWS ARCHIV, 2019, 475 : S76 - S77
12345